Circulating ANGPTL8 concentrations were significantly higher in patients with NAFLD or MAFLD compared with controls (SMD: 0.62, 95%CI: 0.28-0.97; p<0.001). The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.